Cargando…
Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
As the news of approval of COVID-19 vaccination emerge, neurologists across the globe ponder upon whether to use immunotherapies in patients with Multiple Sclerosis (MS). This paper highlights the mechanism of various disease modifying therapies (DMTs) as well as the recently approved Pfizer and Mod...
Autores principales: | Podury, Sanjiti, Khan, Erum, Tandon, Medha, Jaiswal, Shruti, Sriwastava, Shitiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166521/ https://www.ncbi.nlm.nih.gov/pubmed/34275536 http://dx.doi.org/10.1016/j.jocn.2021.05.063 |
Ejemplares similares
-
A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
por: Prasad, Apoorv, et al.
Publicado: (2021) -
COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2
por: Sriwastava, Shitiz, et al.
Publicado: (2021) -
Relevance of CSF, Serum and Neuroimaging Markers in CNS and PNS Manifestation in COVID-19: A Systematic Review of Case Report and Case Series
por: Podury, Sanjiti, et al.
Publicado: (2021) -
Clinical Characteristics and Outcomes of COVID-19 in West Virginia
por: Wen, Sijin, et al.
Publicado: (2021) -
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature
por: Moreno-Escobar, Maria Camila, et al.
Publicado: (2021)